Evidence map›Paper›PMID 24578130›Full record

ArticleJournal of the American Society of Nephrology : JASN2014

Colony-stimulating factor-1 signaling suppresses renal crystal formation.

Kazumi Taguchi, Atsushi Okada, Hiroshi Kitamura, Takahiro Yasui, Taku Naiki, Shuzo Hamamoto, Ryosuke Ando, Kentaro Mizuno, Noriyasu Kawai, Keiichi Tozawa and 4 more

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 2 pooled it
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 2 syntheses or guidelines pooled it, 76 citations in OpenAlex.

  1. Metabolic changes in kidney stone disease.Frontiers in immunology · 2023
    Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. A bibliometric analysis: CaFrontiers in immunology · 2023
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Kazumi TaguchiDepartments of Nephro-urology, and.
Atsushi OkadaDepartments of Nephro-urology, and a-okada@med.nagoya-cu.ac.jp.
Hiroshi KitamuraComparative and Experimental Medicine, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan; and.
Takahiro YasuiDepartments of Nephro-urology, and.
Taku NaikiDepartments of Nephro-urology, and.
Shuzo HamamotoDepartments of Nephro-urology, and.
Ryosuke AndoDepartments of Nephro-urology, and.
Kentaro MizunoDepartments of Nephro-urology, and.
Noriyasu KawaiDepartments of Nephro-urology, and.
Keiichi TozawaDepartments of Nephro-urology, and.
Kenichi AsanoLaboratory of Immune Regulation, School of Science, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.
Masato TanakaLaboratory of Immune Regulation, School of Science, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.
Ichiro MiyoshiComparative and Experimental Medicine, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan; and.
Kenjiro KohriDepartments of Nephro-urology, and.
Institute of Nephro Urology · INNagoya City University · JPTokyo University of Pharmacy and Life Sciences · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We recently reported evidence suggesting that migrating macrophages (Mϕs) eliminate renal crystals in hyperoxaluric mice. Mϕs can be inflammatory (M1) or anti-inflammatory (M2), and colony-stimulating factor-1 (CSF-1) mediates polarization to the M2Mϕ phenotype. M2Mϕs promote renal tissue repair and regeneration, but it is not clear whether these cells are involved in suppressing renal crystal formation. We investigated the role of M2Mϕs in renal crystal formation during hyperoxaluria using CSF-1-deficient mice, which lack M2Mϕs. Compared with wild-type mice, CSF-1-deficient mice had significantly higher amounts of renal calcium oxalate crystal deposition. Treatment with recombinant human CSF-1 increased the expression of M2-related genes and markedly decreased the number of renal crystals in both CSF-1-deficient and wild-type mice. Flow cytometry of sorted renal Mϕs showed that CSF-1 deficiency resulted in a smaller population of CD11b(+)F4/80(+)CD163(+)CD206(hi) cells, which represent M2-like Mϕs. Additionally, transfusion of M2Mϕs into CSF-1-deficient mice suppressed renal crystal deposition. In vitro phagocytosis assays with calcium oxalate monohydrate crystals showed a higher rate of crystal phagocytosis by M2-polarized Mϕs than M1-polarized Mϕs or renal tubular cells. Gene array profiling showed that CSF-1 deficiency resulted in disordered M2- and stone-related gene expressions. Collectively, our results provide compelling evidence for a suppressive role of CSF-1 signaling in renal crystal formation.

Indexed as

AnimalsAnnexin A2Antigens, DifferentiationCalcium OxalateCell Culture TechniquesChemokine CCL2Hyaluronan ReceptorsHyperoxaluriaKidney CalculiMacrophage Colony-Stimulating FactorMacrophagesMaleMiceOsteopontinPhagocytosisRecombinant ProteinsAnnexin A2Antigens, DifferentiationCalcium OxalateChemokine CCL2Hyaluronan ReceptorsMacrophage Colony-Stimulating Factormonocyte-macrophage differentiation antigenOsteopontinRecombinant ProteinsRNA, Messenger

Identifiers

PMID24578130
PMCPMC4116057
OpenAlexW2135109450

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.